Wray, S., Jacques, F., Miller, T. A., Nicholas, J. A., Arroyo, R., Travis, L., . . . Hunter, S. F. (2022). Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study. Multiple sclerosis journal - experimental, translational and clinical, 8(4), 20552173221135888. https://doi.org/10.1177/20552173221135888
Citace podle Chicago (17th ed.)Wray, Sibyl, et al. "Satisfaction with Alemtuzumab in Relapsing Multiple Sclerosis Patients: Results from the Real-world PRO-ACT Study." Multiple Sclerosis Journal - Experimental, Translational and Clinical 8, no. 4 (2022): 20552173221135888. https://doi.org/10.1177/20552173221135888.
Citace podle MLA (9th ed.)Wray, Sibyl, et al. "Satisfaction with Alemtuzumab in Relapsing Multiple Sclerosis Patients: Results from the Real-world PRO-ACT Study." Multiple Sclerosis Journal - Experimental, Translational and Clinical, vol. 8, no. 4, 2022, p. 20552173221135888, https://doi.org/10.1177/20552173221135888.